{"id":"https://genegraph.clinicalgenome.org/r/e0945ba3-2313-43ee-a933-0e0d94f34c2ev1.1","type":"EvidenceStrengthAssertion","dc:description":"FLVCR1 was first reported in relation to autosomal recessive FLVCR1-related retinopathy with or without ataxia (also known as posterior column ataxia-retinitis pigmentosa syndrome; PCARP) in 2010 (Rajadhyaksha et al., PMID: 21070897). This condition is characterized by childhood onset retinal dystrophy and progressive sensory ataxia. At least 321 variants (e.g. missense, in-frame indel, nonsense, frameshift, large deletion, complex rearrangement, etc) have been reported in humans (ClinVar database). \nEvidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. \nThis curation includes 12 variants (missense, frameshift, nonsense, intronic) from 11 probands from 5 publications (Rajadhyaksha et al, 2010, PMID: 21070897; Ishiura et al, 2011, PMID: 21267618; Castori et al, 2017, PMID: 28766925; Kuehlewein et al, 2019, PMID 30656474; Grudzinska Pechhacker et al, 2020, PMID: 32822874) in addition to segregation data (Rajadhyaksha et al, 2010, PMID: 21070897). More data is available in the literature but the maximum score for genetic evidence (12 points) has been reached.\nExperimental evidence included qPCR expression data in mice (Rajadhyaksha et al, 2010, PMID: 21070897), functional studies in patient cells, and a homology model of the protein (Grudzinska Pechhacker et al, 2020, PMID: 32822874).\nIn summary, FLVCR1 has a definitive relationship with FLVCR1-related retinopathy with or without ataxia. This classification was approved by the ClinGen Retina GCEP on August 5, 2021.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/e0945ba3-2313-43ee-a933-0e0d94f34c2e","GCISnapshot":"https://genegraph.clinicalgenome.org/r/7e53e1a9-b1b9-4617-be3a-012399a06ef6","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/7e53e1a9-b1b9-4617-be3a-012399a06ef6_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2022-05-24T22:23:40.253Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/7e53e1a9-b1b9-4617-be3a-012399a06ef6_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2021-08-05T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e53e1a9-b1b9-4617-be3a-012399a06ef6_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e53e1a9-b1b9-4617-be3a-012399a06ef6_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/664af8f3-eba7-4dde-9b6a-3fbe14d9ee79","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c88227dc-df9e-41a0-b21c-a435066564a4","type":"Finding","dc:description":"Flvcr1 mRNA levels were most abundant in the retina, followed by the posterior column of the spinal cord and the cerebellum, as compared to the neocortex, striatum, and hippocampus","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21070897","rdfs:label":"Regional qPCR Studies of Flvcr1 mRNA Expression in Mouse","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7e53e1a9-b1b9-4617-be3a-012399a06ef6_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0ffc48b-d74b-4697-b068-5210a515176f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3264158c-8328-4757-91b6-38285f8c8b4e","type":"FunctionalAlteration","dc:description":"structural shift induced by  steric clashes, most notably producing a rotation of helix-1 around its own center point. The induced structural rotation and changes to  pore composition are  likely to  dramatically change channel function by negatively affecting dynamic pore opening and substrate flow.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32822874","rdfs:label":"homology of FLVCR1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ac1371e4-c5c8-420d-960a-2aa7baf32baa","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9976afc4-35bc-4c94-a420-1e9c6fe1401f","type":"FunctionalAlteration","dc:description":"intracellular heme accumulation was observed in patient compared to healthy donors LCLs following ALA treatment (Figure 2d). Moreover, increased percentage of Annexin V positive cellswas observed in patient compared to healthy donors LCLs, following ALA treatment (Figure 2e). These data indicate that the homozygous p.Pro221Ser FLVCR1 variationcompromise the ability of FLVCR1a to export heme leading to enhanced susceptibility to programmed cell death.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28766925","rdfs:label":"functional consequences of the p.Pro221Ser"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/7e53e1a9-b1b9-4617-be3a-012399a06ef6_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48b55ffd-7e7d-462b-9c73-ef60188e3a41_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48b55ffd-7e7d-462b-9c73-ef60188e3a41","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21070897","rdfs:label":"P10","allele":{"id":"https://genegraph.clinicalgenome.org/r/67ac7e3a-4c22-4614-89fb-7d96a14fad51","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014053.4(FLVCR1):c.721G>A (p.Ala241Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115241"}},"firstTestingMethod":"Homozygosity mapping","secondTestingMethod":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/264a886e-31be-423b-af68-3b7723a26d93_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21070897","allele":{"id":"https://genegraph.clinicalgenome.org/r/67ac7e3a-4c22-4614-89fb-7d96a14fad51"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/264a886e-31be-423b-af68-3b7723a26d93","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/264a886e-31be-423b-af68-3b7723a26d93_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/264a886e-31be-423b-af68-3b7723a26d93_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Based on results using a fluorescent heme analog as a transporter substrate, this variant lost its heme export activity. This was shown to be due to mislocalization - the altered protein does not localize to the plasma membrane but instead localizes to intracellular structures, including lysosomes (PMID: 22483575).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/c913faf7-1519-4136-aa7b-d7933fa6506b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c913faf7-1519-4136-aa7b-d7933fa6506b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32822874","rdfs:label":"32822874_P1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/20cf3bc2-7f86-49d3-be83-7346d91f9cd3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014053.4(FLVCR1):c.730G>A (p.Gly244Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/916537"}},{"id":"https://genegraph.clinicalgenome.org/r/e0038046-7821-4250-a662-458cef3049c7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014053.4(FLVCR1):c.3G>T (p.Met1Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA36896312"}}],"detectionMethod":"patient had several negative clinical gene panel tests, clinical exome sequencing with CNV analysis ","firstTestingMethod":"Exome sequencing","previousTesting":true,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8d068909-e5ab-4dcf-a9bc-59146a43d624_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32822874","allele":{"id":"https://genegraph.clinicalgenome.org/r/e0038046-7821-4250-a662-458cef3049c7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/742b7f6d-19b6-4ab6-92ac-8d6f52dcd09d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32822874","allele":{"id":"https://genegraph.clinicalgenome.org/r/20cf3bc2-7f86-49d3-be83-7346d91f9cd3"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/8d068909-e5ab-4dcf-a9bc-59146a43d624","type":"EvidenceLine","dc:description":"Score reduced because although translation initiation codons may be loss of function in some cases, functional evidence (for a different translation initiation codon) suggests that some normal protein is made (albeit at a much reduced level).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d068909-e5ab-4dcf-a9bc-59146a43d624_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/8d068909-e5ab-4dcf-a9bc-59146a43d624_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"When a different translation initiation codon variant (c.2T>C) was expressed in HEK293FT cells, two gene products were identified on Western blot. A normal product, prduced at decreased levels), and an shorter protein missing the first 203 amino amino acids due to initiation from a downstream ATG (reported in PMID 31408049).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/742b7f6d-19b6-4ab6-92ac-8d6f52dcd09d","type":"EvidenceLine","dc:description":"Score reduced because, although there is evidence for a damaging effect by 3D modeling, no in vitro functional studies have been performed.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/742b7f6d-19b6-4ab6-92ac-8d6f52dcd09d_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/742b7f6d-19b6-4ab6-92ac-8d6f52dcd09d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Predicted damaging by protein 3D modeling (Fig 3).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.25},{"id":"https://genegraph.clinicalgenome.org/r/4e43c721-43ee-4230-9477-b5afb4ea27f8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e43c721-43ee-4230-9477-b5afb4ea27f8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21267618","rdfs:label":"IV-3","allele":{"id":"https://genegraph.clinicalgenome.org/r/7f14b84e-3c42-47ec-839a-da45bd0033e6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014053.4(FLVCR1):c.1477G>C (p.Gly493Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/30775"}},"firstTestingMethod":"Linkage analysis","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/cd3b7020-2c17-49ea-a980-69832c06c879_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21267618","allele":{"id":"https://genegraph.clinicalgenome.org/r/7f14b84e-3c42-47ec-839a-da45bd0033e6"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/cd3b7020-2c17-49ea-a980-69832c06c879","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd3b7020-2c17-49ea-a980-69832c06c879_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/cd3b7020-2c17-49ea-a980-69832c06c879_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"R493 is well conserved. Based on results using a fluorescent heme analog as a transporter substrate, this variant lost its heme export activity. This was shown to be due to mislocalization - the altered protein does not localize to the plasma membrane but instead localizes to intracellular structures, including lysosomes (PMID: 22483575).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/5d80eea6-7662-44a5-882c-cae726c414ff_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d80eea6-7662-44a5-882c-cae726c414ff","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","rdfs:label":"Case 5","ageType":"AgeAtReport","ageUnit":"Years","ageValue":45,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/ce079248-debb-447d-b552-9494b73eca28","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014053.4(FLVCR1):c.1158T>G (p.Ile386Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1386068"}},{"id":"https://genegraph.clinicalgenome.org/r/dbdb0172-82b3-484f-8aff-d16f1ca7b823","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014053.4(FLVCR1):c.202C>T (p.Gln68Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA344795514"}}],"firstTestingMethod":"Next generation sequencing panels","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/5e227758-3cf3-4514-8a90-78a6eb18443d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce079248-debb-447d-b552-9494b73eca28"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/95c22777-a9c5-4ff6-884e-329f1c2462a5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","allele":{"id":"https://genegraph.clinicalgenome.org/r/dbdb0172-82b3-484f-8aff-d16f1ca7b823"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/95c22777-a9c5-4ff6-884e-329f1c2462a5","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95c22777-a9c5-4ff6-884e-329f1c2462a5_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5e227758-3cf3-4514-8a90-78a6eb18443d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e227758-3cf3-4514-8a90-78a6eb18443d_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/98fd35cc-5b44-4da5-b813-e8ca2c763261_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98fd35cc-5b44-4da5-b813-e8ca2c763261","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21070897","rdfs:label":"VI-2","allele":{"id":"https://genegraph.clinicalgenome.org/r/83d9a5b2-2df3-4d5c-aab3-3fdd60c4c714","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014053.4(FLVCR1):c.574T>C (p.Cys192Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115242"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Homozygosity mapping","secondTestingMethod":"Linkage analysis","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/299abcd9-3481-4583-b685-34b8ca6a3b6e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21070897","allele":{"id":"https://genegraph.clinicalgenome.org/r/83d9a5b2-2df3-4d5c-aab3-3fdd60c4c714"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/299abcd9-3481-4583-b685-34b8ca6a3b6e","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/299abcd9-3481-4583-b685-34b8ca6a3b6e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/299abcd9-3481-4583-b685-34b8ca6a3b6e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Based on results using a fluorescent heme analog as a transporter substrate, this variant lost its heme export activity. This was shown to be due to mislocalization - the altered protein does not localize to the plasma membrane but instead localizes to intracellular structures, including lysosomes (PMID: 22483575).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/775a4123-3e35-4eff-8fef-cb62aaa38ebb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/775a4123-3e35-4eff-8fef-cb62aaa38ebb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","rdfs:label":"Case 4","ageType":"AgeAtReport","ageUnit":"Years","ageValue":22,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/54b0307a-24c4-4e03-b0fa-588a54e7a7c9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014053.4(FLVCR1):c.755del (p.Gly252fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/872563"}},{"id":"https://genegraph.clinicalgenome.org/r/e9f9892c-d3ef-4fd1-a3ad-c0826e49b4be","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014053.4(FLVCR1):c.1092+5G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1386046"}}],"firstTestingMethod":"Next generation sequencing panels","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/c58308fb-79f4-4ada-9ffb-c93b5eb4392e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","allele":{"id":"https://genegraph.clinicalgenome.org/r/e9f9892c-d3ef-4fd1-a3ad-c0826e49b4be"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/f43ca854-d7c8-4c1d-9af9-6961c76ad742_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","allele":{"id":"https://genegraph.clinicalgenome.org/r/54b0307a-24c4-4e03-b0fa-588a54e7a7c9"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/f43ca854-d7c8-4c1d-9af9-6961c76ad742","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f43ca854-d7c8-4c1d-9af9-6961c76ad742_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c58308fb-79f4-4ada-9ffb-c93b5eb4392e","type":"EvidenceLine","dc:description":"Reduced due to weak functional evidence. Likely hypomorph.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c58308fb-79f4-4ada-9ffb-c93b5eb4392e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c58308fb-79f4-4ada-9ffb-c93b5eb4392e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RT-PCR and mini-gene assays suggest that this variant may result in a mild, leaky splicing defect resulting in skipping of exon 4 in some transcript but also normal splicing. This variant is likely hypomorphic.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/ab07de70-56da-4018-8e57-bc23bc6349df_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab07de70-56da-4018-8e57-bc23bc6349df","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","rdfs:label":"Case 6","ageType":"AgeAtReport","ageUnit":"Years","ageValue":49,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e9f9892c-d3ef-4fd1-a3ad-c0826e49b4be"},"firstTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d3b2b386-d671-49f7-a11b-2275fa7e15c9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","allele":{"id":"https://genegraph.clinicalgenome.org/r/e9f9892c-d3ef-4fd1-a3ad-c0826e49b4be"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/d3b2b386-d671-49f7-a11b-2275fa7e15c9","type":"EvidenceLine","dc:description":"Weak functional evidence. LIkely hypomorph.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d3b2b386-d671-49f7-a11b-2275fa7e15c9_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d3b2b386-d671-49f7-a11b-2275fa7e15c9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RT-PCR and mini-gene assays suggest that this variant may result in a mild, leaky splicing defect resulting in skipping of exon 4 in some transcript but also normal splicing. This variant is likely hypomorphic.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/11225350-185e-454d-8f86-43ceaf688f68_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11225350-185e-454d-8f86-43ceaf688f68","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28766925","rdfs:label":"28766925_P1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":33,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1ce74e98-aa0e-4c0d-a472-f9e93545dca3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014053.4(FLVCR1):c.661C>T (p.Pro221Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1385924"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"HSAN","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/39042278-84c4-4bb4-8463-986203e4c379_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28766925","allele":{"id":"https://genegraph.clinicalgenome.org/r/1ce74e98-aa0e-4c0d-a472-f9e93545dca3"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/39042278-84c4-4bb4-8463-986203e4c379","type":"EvidenceLine","dc:description":"Scored reduced because functional studies in patient cells are not included here but scored under functional alteration.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39042278-84c4-4bb4-8463-986203e4c379_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/39042278-84c4-4bb4-8463-986203e4c379_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies in patient-derived lumphoblasts scored under functional alteration.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/4971efc3-09e2-4e56-87db-08555d29c254_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4971efc3-09e2-4e56-87db-08555d29c254","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21070897","rdfs:label":"P11","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a5808b8-2b38-49d7-90f3-3bdcd0ce85d6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014053.4(FLVCR1):c.361A>G (p.Asn121Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115240"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Homozygosity mapping","secondTestingMethod":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e2f93bc8-d348-40a5-9b5c-115d49d795f3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21070897","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a5808b8-2b38-49d7-90f3-3bdcd0ce85d6"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/e2f93bc8-d348-40a5-9b5c-115d49d795f3","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2f93bc8-d348-40a5-9b5c-115d49d795f3_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e2f93bc8-d348-40a5-9b5c-115d49d795f3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Based on results using a fluorescent heme analog as a transporter substrate, this variant lost its heme export activity. This was shown to be due to mislocalization - the altered protein does not localize to the plasma membrane but instead localizes to intracellular structures, including lysosomes (PMID: 22483575).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/7e53e1a9-b1b9-4617-be3a-012399a06ef6_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa757c99-7eca-482a-9926-d5a0e8fa8ee5_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21267618","rdfs:label":"21267618_F1","family":{"id":"https://genegraph.clinicalgenome.org/r/aa757c99-7eca-482a-9926-d5a0e8fa8ee5","type":"Family","rdfs:label":"21267618_F1","member":{"id":"https://genegraph.clinicalgenome.org/r/4e43c721-43ee-4230-9477-b5afb4ea27f8"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/4e43c721-43ee-4230-9477-b5afb4ea27f8"},"publishedLodScore":1.93,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/7b24937a-ea44-4ac8-b120-58ba1526f785_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21070897","rdfs:label":"21070897_Fam1","estimatedLodScore":6.34,"family":{"id":"https://genegraph.clinicalgenome.org/r/7b24937a-ea44-4ac8-b120-58ba1526f785","type":"Family","rdfs:label":"21070897_Fam1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/4971efc3-09e2-4e56-87db-08555d29c254"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":17,"phenotypePositiveAllelePositive":8,"proband":{"id":"https://genegraph.clinicalgenome.org/r/4971efc3-09e2-4e56-87db-08555d29c254"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/27fa558b-29f4-4113-9393-91f146cccf33_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21070897","rdfs:label":"21070897_Fam3","family":{"id":"https://genegraph.clinicalgenome.org/r/27fa558b-29f4-4113-9393-91f146cccf33","type":"Family","rdfs:label":"21070897_Fam3","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/98fd35cc-5b44-4da5-b813-e8ca2c763261"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/98fd35cc-5b44-4da5-b813-e8ca2c763261"},"publishedLodScore":3,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/b5ae0dcd-e979-491f-a3e2-4ddc0f7ce042_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","rdfs:label":"30656474_F1","family":{"id":"https://genegraph.clinicalgenome.org/r/b5ae0dcd-e979-491f-a3e2-4ddc0f7ce042","type":"Family","rdfs:label":"30656474_F1","member":{"id":"https://genegraph.clinicalgenome.org/r/3ee1a9d1-8d72-409d-afb9-cc5a2c6510cd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","rdfs:label":"Case 2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":21,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/e9f9892c-d3ef-4fd1-a3ad-c0826e49b4be"},{"id":"https://genegraph.clinicalgenome.org/r/54b0307a-24c4-4e03-b0fa-588a54e7a7c9"}],"firstTestingMethod":"Next generation sequencing panels","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/578b72a9-ad8c-4e35-ab93-8956cda6dbbb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","allele":{"id":"https://genegraph.clinicalgenome.org/r/54b0307a-24c4-4e03-b0fa-588a54e7a7c9"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/cee12fe8-dd5e-44ec-a78e-67a6fbdc7a8b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","allele":{"id":"https://genegraph.clinicalgenome.org/r/e9f9892c-d3ef-4fd1-a3ad-c0826e49b4be"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/3ee1a9d1-8d72-409d-afb9-cc5a2c6510cd"}},{"id":"https://genegraph.clinicalgenome.org/r/65b7d0ac-d378-4924-9450-217911f7ecf1_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21070897","rdfs:label":"21070897_Fam2","estimatedLodScore":3.56,"family":{"id":"https://genegraph.clinicalgenome.org/r/65b7d0ac-d378-4924-9450-217911f7ecf1","type":"Family","rdfs:label":"21070897_Fam2","member":{"id":"https://genegraph.clinicalgenome.org/r/48b55ffd-7e7d-462b-9c73-ef60188e3a41"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":14,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/48b55ffd-7e7d-462b-9c73-ef60188e3a41"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3ee1a9d1-8d72-409d-afb9-cc5a2c6510cd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ee1a9d1-8d72-409d-afb9-cc5a2c6510cd"},{"id":"https://genegraph.clinicalgenome.org/r/578b72a9-ad8c-4e35-ab93-8956cda6dbbb","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/578b72a9-ad8c-4e35-ab93-8956cda6dbbb_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cee12fe8-dd5e-44ec-a78e-67a6fbdc7a8b","type":"EvidenceLine","dc:description":"Decreased due to weak functional evidence.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cee12fe8-dd5e-44ec-a78e-67a6fbdc7a8b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/cee12fe8-dd5e-44ec-a78e-67a6fbdc7a8b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RT-PCR and mini-gene assays suggest that this variant may result in a mild, leaky splicing defect resulting in skipping of exon 4 in some transcript but also normal splicing. This variant is likely hypomorphic.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/961c8385-ec1a-4196-b141-533854e1823d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/961c8385-ec1a-4196-b141-533854e1823d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","rdfs:label":"Case 3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":53,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/e9f9892c-d3ef-4fd1-a3ad-c0826e49b4be"},{"id":"https://genegraph.clinicalgenome.org/r/0dc5bdd0-1fa4-476e-a950-b81137004fa7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014053.4(FLVCR1):c.847G>C (p.Ala283Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1385976"}}],"firstTestingMethod":"Next generation sequencing panels","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d2b8418e-f40c-4fe4-a597-c0559ae045ec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","allele":{"id":"https://genegraph.clinicalgenome.org/r/0dc5bdd0-1fa4-476e-a950-b81137004fa7"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/0c190cf7-c688-436f-8176-2c7be10b3fb0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656474","allele":{"id":"https://genegraph.clinicalgenome.org/r/e9f9892c-d3ef-4fd1-a3ad-c0826e49b4be"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/d2b8418e-f40c-4fe4-a597-c0559ae045ec","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2b8418e-f40c-4fe4-a597-c0559ae045ec_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0c190cf7-c688-436f-8176-2c7be10b3fb0","type":"EvidenceLine","dc:description":"Weak functional evidence. LIkely hypomorph.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c190cf7-c688-436f-8176-2c7be10b3fb0_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0c190cf7-c688-436f-8176-2c7be10b3fb0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RT-PCR and mini-gene assays suggest that this variant may result in a mild, leaky spliing defect resulting in skipping of exon 4 in some transcript but also normal splicing. This variant is likely hypomorphic.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":4487,"specifiedBy":"GeneValidityCriteria8","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/l2l8CgriDeA","type":"GeneValidityProposition","disease":"obo:MONDO_0100449","gene":"hgnc:24682","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_7e53e1a9-b1b9-4617-be3a-012399a06ef6-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}